You are now viewing our public site. Back to Dashboard

Lymphedema Gold Standard Therapy: Risk Management and Adaptations

presented by Steve Norton, CLT-LANA

Accrediting Body:

Target Audience:

Disclosure Statement:

Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.

MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.

Accreditation Check:

In this course, Steve Norton expands on the fundamentals of lymphedema to address proper therapy standards, precautions and applications of complete decongestive therapy (CDT). He further addresses serious concerns to patients and practitioners including the risk factors for lymphedema and risk reduction, as well as the benefits to early intervention. In this course, the instructor will meet with Vera, a long-term lymphedema patient, to learn about her treatment, what made it successful, and what red flags were identified early on in the process. Upon completion of this course, the participant will understand how to successfully and knowledgeably manage care of the lymphedema patient.

Meet Your Instructor

Steve Norton, CLT-LANA

Steve was certified in 1993 in Manual Lymph Drainage and Complete Decongestive Therapy through Lerner Lymphedema Services, PC the first fully specialized lymphedema treatment facility in the United States. He became the Chief Therapist of the Lerner Lymphedema Services, P.C. clinics located in Princeton, NJ, Manhattan, NYC and New Brunswick, NJ from 1994-1999. Over this…

Read full bio

Chapters & Learning Objectives

Download Learning Objectives Download Learning Objectives

Enter your information to unlock the learning objectives.

Thank you!

Download the learning objectives for Lymphedema Gold Standard Therapy: Risk Management and Adaptations.

Download Learning Objectives

1. Lymphedema Staging and Risk Stratification

This chapter emphasizes the therapeutic approaches that are utilized to reduce lymphedema. Participants will learn to appreciate the rationale for Complete Decongestive Therapy as opposed to singular approaches such as; pneumatic compression pumps, medications, elevation, compression garments or surgery. In addition, the benefits of Manual Lymph Drainage on an impaired lymphatic system and swollen body area will be discussed. Upon completion, participants will be able to gauge the contraindications to compression and Manual Lymph Drainage for persons seeking therapy.

2. Complete Decongestive Therapy (CDT) and Other Therapies

Many red flags are associated with CDT as an intervention. This chapter will discuss the clinical reasoning of these red flags as well as the importance of a referral to a lymphedema specialist. The participant will also learn the limitations of an untrained therapist and the risks of using common modalities with a lymphedema patient. Other critical interventions for lymphedema will also be covered.

3. Applications of CDT for Various Clinical Presentations

The gold standard therapy includes early identification and intervention. In this chapter, the participant will learn how to promote early interventions as well as the many ways an at-risk patient can reduce their chances of developing lymphedema.

Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.

Join our newsletter to get the latest updates delivered straight to your inbox.

MedBridge blog posts and emails

Request a Demo

For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.

Contact Sales

Contact sales to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.